12 Feb 2013 18:01
PuriCore plc
("PuriCore" or the "Company")
12 February 2013
Share Option Grant and Blocklisting Application Update
PuriCore (LSE: PURI), the water-based clean technology company, announces today a share option grant, in accordance with the Disclosure and Transparency Rules. On 8 February, PuriCore issued share options to a Company Non-Executive Director as set forth below. The share options have an exercise price of 40p, which is the closing market price of the Company's ordinary shares on 8 February 2013, and a five-year term.
Name and title | Number of share options granted | Vesting |
Daniel Hegglin Non-Executive Director | 35,000 | Half on 8 February 2014; half on 8 February 2015 |
In addition, for administrative reasons, the Company has determined that the blocklisting application submitted and announced on 7 February will no longer be required and has therefore withdrawn the application.
Enquiries:
FTI Consulting
Susan Quigley / Simon Conway / Victoria Foster Mitchell
+44 (0) 20 7831 3113
About PuriCore
PuriCoreplc (LSE: PURI) is a water-based clean technology company focused on developing and commercialising proprietary solutions that protect people from the spread of infectious pathogens without causing harm to human health or the environment. The Company's products are used in a broad range of markets that depend upon effective pathogen control. PuriCore is the leading full provider of all products and services required for a safe, efficient, and compliant endoscope decontamination to protect patients in UK hospitals. The Company's products are the standard for food safety and are used for floral care in leading US supermarket chains. PuriCore also offers a breakthrough wound therapy solution to treat chronic and acute wounds including diabetic ulcers and burns. PuriCore is headquartered in Malvern, Pennsylvania, with operations in Stafford and Clevedon, UK. To receive additional information on PuriCore, visit www.puricore.com, which does not form part of this announcement.